Discovery could lead to more effective treatments for cancers

Plus, Oc­u­lar Ther­a­peu­tix’s pri­vate place­ment, Lim­maT­e­ch Bi­o­log­ics’ shigel­losis vac­cine da­ta and a col­lab­o­ra­tion be­tween Hox Ther­a­peu­tics and Ver­nalis. MD An­der­son buys tech from Bel­licum: The Texas

Re­peat biotech founder Alex­is Borisy will have to give up at least two of his pub­lic board seats with­in a year, since the in­vestor is